EDGAR Filing Documents for 0001737287-20-000032

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001737287-20-000032

Filing Date

2020-06-01

Accepted

2020-06-01 06:38:42

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	allo-20200601x424bprospect.htm	424B5	608019
2	GRAPHIC	image_01.jpg	GRAPHIC	7772
3	GRAPHIC	image_02.jpg	GRAPHIC	26743
4	GRAPHIC	image_11.jpg	GRAPHIC	56638
	Complete submission text file	0001737287-20-000032.txt		734945

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700

Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-234516 | Film No.: 20930865
SIC: 2836 Biological Products, (No Diagnostic Substances)